C. diff infections contribute to much higher hospital costs

Along with devastating the health of patients already recovering from some other medical malady, the hospital-acquired infection Clostridium difficile is also a financial hardship for hospitals. According to a new study by group purchasing giant Premier, Inc. and Cubist Pharmaceuticals, each case of C. diff raises an individual patient's cost of care by 40 percent, or $7,285 on average. Their length of stay also increases an average of 55 percent, or nearly five days on average. Moreover, patients who contract C. diff are also 77 percent more likely of being readmitted to the hospital within 30 days of discharge than those patients who are not infected. Read the full article at FierceHealthcare

Suggested Articles

Humana has filed suit against the Trump administration over cost-sharing reduction payments.

The Trump administration has launched a new alternative payment model to provide upfront investments to rural healthcare providers.

Nurx raised an additional $22.5 million in funding in May. Find out why CEO Varsha Rao believes telehealth will not go back to pre-COVID-19 levels.